| Sharing Excellence |
| Video Clips |
| Book Reviews |
| News / Articles |
| HOME |
| ABOUT IDEA |
| STRATEGY AT PHASE II |
| MEASURING |
| SHARING |
| CONTACT IDEA |
| USEFUL LINKS |
| IDEA Junkie |
| IDEA Collider |
| | CLIENT AREA |
IDEA Pharma is delighted to announce the appointment of Dr. Graham Walker to its IDEAtion team. Join..
IDEA Pharma has launched the second annual Productive Innovation Index (PII), ranking 21 global phar..
For a closer look, go to: http://www.samedanltd.com/magazine/current/12 Lifecycle decisions are ..
For something that is supposed to be so clear, the terms used in Pharma strategy can cause confu..
With IDEA Pharma’s US operations securing an ever-stronger foothold, awareness is growing as t..
As IDEA Pharma widens its net across Europe, business is booming as the ‘IDEA house’..
As the ‘IDEA revolution’ continues to make waves within Pharma, more and more compan..
IDEA Pharma’s Principal IDEAtor, Mike Rea, has been voted among the PharmaVOICE Top 100 Mo..
The industry has a well-recognised problem. There is a prevailing view that developing drugs is ..
IDEA Pharma makes public its annual Productive Innovation Index (PII) With only one in four ..
IDEAtion is the process of building IDEAs. IDEAtion ensures the potential or the talent of a mol..
This is not an industry that does what is easy instead of what is best. This is not an industry ..
It used to be that those involved in the process of communication understood which part of the p..
Here’s the thing about Efficacy. It doesn’t exist. It is an abstract concept, a shorthan..
Cards on the table: no two ‘scenario planning’ projects are the same, or should be t..
As IDEA Pharma widens its net across Europe, business is booming as the ‘IDEA house’ continues to help companies achieve productive innovation and better path-to-market options for their molecules. IDEA welcomes the recent appointments of Suzanne Axford-Bryars and Lidia Markovic as Project Managers to the team.
Starting life out working as a molecular biologist for Novartis, Suzanne moved into medical writing before making the transition to account management. With10 years’ experience in consultancy, Suzanne specialised in directing brand portfolios for big Pharma clients. Having previously worked for IDEA, Suzanne left to experience working in Italy for a medical education and healthcare advertising firm. Commenting on her return to IDEA, Suzanne said: “IDEA has always struck a chord that resonated with me. Having worked in several consultancies across our industry, the methods adopted in the main were process driven, standardised and often lacked creativity and imagination. IDEA’s approach to strategic differentiation for its clients falls into a completely different realm. IDEA doesn’t function as a consultancy; it operates differently in every way, from creative thinking, its ethos, and the people it employs, through to how the company interacts with its client base… which is something that I really missed. Innovation happens organically and ideas are born from a shared passion in changing how the industry currently operates.”
Lidia joins IDEA from Movianto UK (part of the Celesio Group), the healthcare and pharmaceutical distribution specialists, where she acted as key account manager, responsible for Top Ten Pharma clients including Pfizer and Bayer. With 8 years’ project management experience within the pharmaceutical industry at product delivery and distribution level, she now wants to work at the other end of the spectrum, helping to push new molecules into exciting areas of opportunity.
“Pharma is such a diverse industry of opportunity… and IDEA is a company that really offers diverse challenges every day. I look forward to continuing to build key relationships with IDEA’s growing client base and broadening my knowledge further. The team at IDEA is fantastic and all share the same outlook at changing standardised industry behaviour. I am delighted to be part of the movement,” said Lidia.
“Our standing in Europe is getting stronger day-by-day, which means more companies are asking us to help redefine their innovation processes. With more and more new clients joining us each week, I am delighted to have both Lidia and Suzanne on board… their skill set with be invaluable in helping us to deliver transformational solutions to our clients,” concludes Mike Rea, CEO.